Now Available for Both Cerebral and Somatic Applications and for All Patient Populations, O3’s Delta Hemoglobin Parameters Offer Clinicians Additional Insight Into Changes in Tissue Oxygen Saturation ...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Critical Care in which researchers in Genoa, Italy, ...
Irvine, Calif.-based Masimo released three clinical studies that evaluate its noninvasive patient monitoring technologies and presented them at the International Anesthesia Research Society’s Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback